0001144204-16-141020.txt : 20161222 0001144204-16-141020.hdr.sgml : 20161222 20161222170032 ACCESSION NUMBER: 0001144204-16-141020 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161222 DATE AS OF CHANGE: 20161222 EFFECTIVENESS DATE: 20161222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rasna Therapeutics Inc. CENTRAL INDEX KEY: 0001582249 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 392080103 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-276930 FILM NUMBER: 162067216 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-398-4627 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: Active With Me Inc. DATE OF NAME CHANGE: 20130723 D 1 primary_doc.xml X0707 D LIVE 0001582249 Rasna Therapeutics Inc. 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY NEW YORK 10170 646-396-4087 NEVADA Active With Me, Inc. Active With Me Inc. Corporation true 2012 James Tripp 420 Lexington Avenue Suite 2525 New York NY NEW YORK 10170 Executive Officer Director Tiziano Lazzaretti 420 Lexington Avenue Suite 2525 New York NY NEW YORK 10170 Executive Officer Kunwar Shailubhai 420 Lexington Avenue Suite 2525 New York NY NEW YORK 10170 Director Riccardo Dalla-Favera 420 Lexington Avenue Suite 2525 New York NY NEW YORK 10170 Director Jim Mervis 420 Lexington Avenue Suite 2525 New York NY NEW YORK 10170 Director John Brancaccio 420 Lexington Avenue Suite 2525 New York NY NEW YORK 10170 Director Alessandro Padova 420 Lexington Avenue Suite 2525 New York NY NEW YORK 10170 Director John Alex Martin 420 Lexington Avenue Suite 2525 New York NY NEW YORK 10170 Director Biotechnology Decline to Disclose 06b false 2016-12-20 false true false 25000 10000000 2020000 7980000 false 5 0 0 0 false Rasna Therapeutics Inc. /s/ Tiziano Lazzaretti Tiziano Lazzaretti Chief Financial Officer 2016-12-22